These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

110 related articles for article (PubMed ID: 12888486)

  • 1. A statistical model of diurnal variation in human growth hormone.
    Klerman EB; Adler GK; Jin M; Maliszewski AM; Brown EN
    Am J Physiol Endocrinol Metab; 2003 Nov; 285(5):E1118-26. PubMed ID: 12888486
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Tripartite neuroendocrine activation of the human growth hormone (GH) axis in women by continuous 24-hour GH-releasing peptide infusion: pulsatile, entropic, and nyctohemeral mechanisms.
    Shah N; Evans WS; Bowers CY; Veldhuis JD
    J Clin Endocrinol Metab; 1999 Jun; 84(6):2140-50. PubMed ID: 10372723
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Continuous 24-hour intravenous infusion of recombinant human growth hormone (GH)-releasing hormone-(1-44)-amide augments pulsatile, entropic, and daily rhythmic GH secretion in postmenopausal women equally in the estrogen-withdrawn and estrogen-supplemented states.
    Evans WS; Anderson SM; Hull LT; Azimi PP; Bowers CY; Veldhuis JD
    J Clin Endocrinol Metab; 2001 Feb; 86(2):700-12. PubMed ID: 11158034
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Temporal structure of in vivo growth hormone secretory events in humans.
    Hartman ML; Faria AC; Vance ML; Johnson ML; Thorner MO; Veldhuis JD
    Am J Physiol; 1991 Jan; 260(1 Pt 1):E101-10. PubMed ID: 1987784
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A stochastic differential equation model of diurnal cortisol patterns.
    Brown EN; Meehan PM; Dempster AP
    Am J Physiol Endocrinol Metab; 2001 Mar; 280(3):E450-61. PubMed ID: 11171600
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Impact of estradiol supplementation on dual peptidyl drive of GH secretion in postmenopausal women.
    Veldhuis JD; Evans WS; Bowers CY
    J Clin Endocrinol Metab; 2002 Feb; 87(2):859-66. PubMed ID: 11836333
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A mathematical model of diurnal variations in human plasma melatonin levels.
    Brown EN; Choe Y; Shanahan TL; Czeisler CA
    Am J Physiol; 1997 Mar; 272(3 Pt 1):E506-16. PubMed ID: 9124558
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Appraisal of growth hormone (GH) secretion: evaluation of a composite pharmacokinetic model that discriminates multiple components of GH input.
    Bright GM; Veldhuis JD; Iranmanesh A; Baumann G; Maheshwari H; Lima J
    J Clin Endocrinol Metab; 1999 Sep; 84(9):3301-8. PubMed ID: 10487702
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Fasting as a metabolic stress paradigm selectively amplifies cortisol secretory burst mass and delays the time of maximal nyctohemeral cortisol concentrations in healthy men.
    Bergendahl M; Vance ML; Iranmanesh A; Thorner MO; Veldhuis JD
    J Clin Endocrinol Metab; 1996 Feb; 81(2):692-9. PubMed ID: 8636290
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Time mode of growth hormone (GH) entry into the bloodstream and steady-state plasma GH concentrations, rather than sex, estradiol, or menstrual cycle stage, primarily determine the GH elimination rate in healthy young women and men.
    Shah N; Aloi J; Evans WS; Veldhuis JD
    J Clin Endocrinol Metab; 1999 Aug; 84(8):2862-9. PubMed ID: 10443692
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Age and relative adiposity are specific negative determinants of the frequency and amplitude of growth hormone (GH) secretory bursts and the half-life of endogenous GH in healthy men.
    Iranmanesh A; Lizarralde G; Veldhuis JD
    J Clin Endocrinol Metab; 1991 Nov; 73(5):1081-8. PubMed ID: 1939523
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Oral estradiol administration modulates continuous intravenous growth hormone (GH)-releasing peptide-2-driven GH secretion in postmenopausal women.
    Shah N; Evans WS; Bowers CY; Veldhuis JD
    J Clin Endocrinol Metab; 2000 Aug; 85(8):2649-59. PubMed ID: 10946861
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A longitudinal assessment of hormonal and physical alterations during normal puberty in boys. III. The neuroendocrine growth hormone axis during late prepuberty.
    Martha PM; Rogol AD; Veldhuis JD; Blizzard RM
    J Clin Endocrinol Metab; 1996 Nov; 81(11):4068-74. PubMed ID: 8923862
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Lowering total plasma insulin-like growth factor I concentrations by way of a novel, potent, and selective growth hormone (GH) receptor antagonist, pegvisomant (B2036-peg), augments the amplitude of GH secretory bursts and elevates basal/nonpulsatile GH release in healthy women and men.
    Veldhuis JD; Bidlingmaier M; Anderson SM; Wu Z; Strasburger CJ
    J Clin Endocrinol Metab; 2001 Jul; 86(7):3304-10. PubMed ID: 11443205
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The orderliness of the growth hormone (GH) release process and the mean mass of GH secreted per burst are highly conserved in individual men on successive days.
    Friend K; Iranmanesh A; Veldhuis JD
    J Clin Endocrinol Metab; 1996 Oct; 81(10):3746-53. PubMed ID: 8855833
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Diurnal variation in the elimination rate of human growth hormone (GH): the half-life of serum GH is prolonged in the evening, and affected by the source of the hormone, as well as by body size and serum estradiol.
    Holl RW; Schwarz U; Schauwecker P; Benz R; Veldhuis JD; Heinze E
    J Clin Endocrinol Metab; 1993 Jul; 77(1):216-20. PubMed ID: 8325945
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Pubertal alterations in growth and body composition: IX. Altered spontaneous secretion and metabolic clearance of growth hormone in overweight youth.
    Roemmich JN; Clark PA; Weltman A; Veldhuis JD; Rogol AD
    Metabolism; 2005 Oct; 54(10):1374-83. PubMed ID: 16154439
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Short-term estradiol supplementation augments growth hormone (GH) secretory responsiveness to dose-varying GH-releasing peptide infusions in healthy postmenopausal women.
    Anderson SM; Shah N; Evans WS; Patrie JT; Bowers CY; Veldhuis JD
    J Clin Endocrinol Metab; 2001 Feb; 86(2):551-60. PubMed ID: 11158008
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Apparently complete restoration of normal daily adrenocorticotropin, cortisol, growth hormone, and prolactin secretory dynamics in adults with Cushing's disease after clinically successful transsphenoidal adenomectomy.
    Veldman RG; Frölich M; Pincus SM; Veldhuis JD; Roelfsema F
    J Clin Endocrinol Metab; 2000 Nov; 85(11):4039-46. PubMed ID: 11095430
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A quantitative estimation of growth hormone secretion in normal man: reproducibility and relation to sleep and time of day.
    Van Cauter E; Kerkhofs M; Caufriez A; Van Onderbergen A; Thorner MO; Copinschi G
    J Clin Endocrinol Metab; 1992 Jun; 74(6):1441-50. PubMed ID: 1592892
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.